Quantcast

Latest DNA Chip Stories

2009-08-05 10:41:00

CARLISLE, Mass., Aug. 5 /PRNewswire/ -- CapitalBio Corporation and VigeneTech Inc. have announced the launch of a fully integrated microarray solution platform. CapitalBio Corp., a developer and marketer of diagnostic biochips and advanced microarray instrument systems, in collaboration with VigeneTech, developers of novel image analysis, automation, and instrumentation software, now offers a platform that combines the superior performance and "one-click" automation of the MicroVigene(TM)...

2009-08-05 07:57:00

CARLSBAD, Calif., Aug. 5 /PRNewswire/ -- GenVault Corporation is pleased to report that their DNA recovery product, GenSolve(TM), is enabling independent groups, from diverse research areas, to recover DNA from Guthrie cards and FTA paper for microarray based genomic analysis and Illumina iSelect based genotyping. Two publications, BMC Research Notes 2009, 2:107 (16 June 2009) and BMC Genetics 2009, 10:38 (22 July 2009) www.biomedcentral.com, illustrate that GenSolve(TM) methodology is...

2009-05-22 10:10:00

The widely-used Affymetrix Whole-Transcript Gene 1.0 ST (sense target) microarray platform, normally used to assay gene expression, can also be utilized to interrogate exon-specific splicing. Research published today in the open access journal BMC Bioinformatics shows scientists how to monitor alternative splicing activity on a genome-wide scale, without investing in new exon microarray technologies.Alternative splicing produces a variety of mRNA transcripts from a single gene by splicing...

2008-11-06 11:17:54

Signature Genomic Laboratories, a provider of microarray-based cytogenetic diagnostics, has launched a new enhanced microarray for the prenatal detection of chromosome abnormalities that result in missing or extra pieces of DNA. The first tier of Signature's prenatal service, the enhanced PrenatalChip targets over 100 discrete chromosomal regions, the gain or loss of which results in a genetic disorder, while minimizing coverage of regions of unknown clinical significance. Signature's...

2008-11-05 12:00:30

Signature Genomic Laboratories announced the release of an enhanced microarray for the prenatal detection of chromosome abnormalities that result in missing or extra pieces of DNA. The first tier of Signature's Prenatal Service, the enhanced PrenatalChip(R) targets over 100 discrete chromosomal regions, the gain or loss of which results in a genetic disorder, while minimizing coverage of regions of unknown clinical significance. Signature's whole-genome microarray, the SignatureChipWG,...

2008-10-31 09:00:28

SUNNYVALE, Calif., Oct. 31 /PRNewswire/ -- Pathwork Diagnostics, a molecular diagnostics company focused on oncology, will present three studies involving the gene expression based Pathwork(R) Tissue of Origin Test at the Association for Molecular Pathology (AMP) Annual Meeting. In a poster entitled, "Gene Expression Microarray-Based Diagnostic Test May Identify Primary Tumor Site in Patients with Carcinoma of Unknown Primary (CUP)," Fabiola Medeiros, MD, Assistant Professor of Laboratory...

2008-10-30 09:00:40

Finnish biotechnology company Mobidiag launches its first CE-marked product for In Vitro Diagnostics (IVD) of sepsis. The microarray-based Prove-it(TM) Sepsis is invincible in both the coverage and the rate of detecting dangerous bacteria including the superbug MRSA from positive blood culture samples in a single test. The test enables simultaneous identification of 50 species in less than three hours. Based on the excellent performance of 3300 patient samples in the University College London...

2008-08-27 03:00:26

By Zhao, Qiao Brkljacic, Jelena; Meier, Iris Ran GTPase plays essential roles in multiple cellular processes, including nucleocytoplasmic transport, spindle formation, and postmitotic nuclear envelope (NE) reassembly. The cytoplasmic Ran GTPase activating protein RanGAP is critical to establish a functional RanGTP/RanGDP gradient across the NE and is associated with the outer surface of the NE in metazoan and higher plant cells. Arabidopsis thaliana RanGAP association with the root tip NE...

2008-08-26 15:01:06

Signature Genomic Laboratories, a company that specializes in microarray-based diagnostic testing of genetic disease in individuals with mental retardation and birth defects, announced it has waived the 25% deposit previously required of patients for insurance billing. Rather than pay a deposit prior to the initiation of testing, patients with private insurance can request an insurance benefits investigation prior to or concurrent with sample processing through Signature's recently...

2008-08-18 12:00:55

Researchers at Signature Genomic Laboratories recently published the first large-scale prospective study comparing the detection rate of chromosomal abnormalities--missing or extra pieces of DNA--by microarray analysis in prenatal cases to that of neonatal cases referred with a variety of clinical findings, including congenital anomalies. In the study, the findings of which will appear in the September issue of the journal Prenatal Diagnosis and were electronically published July 22,...


Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related